Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
Although the incidence of severe cutaneous adverse reactions (SCARs) to medications is very low, SCARs can result in disability or even death if they are not diagnosed and treated properly. As the rapid recognition of SCARs is essential, it is necessary to develop diagnostic markers for them that ca...
Main Authors: | Fumi Miyagawa, Hideo Asada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/6/847 |
Similar Items
-
Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
by: Fabrizio De Luca, et al.
Published: (2017-10-01) -
Dermatological adverse drug reactions with particular reference to Steven-Johnson syndrome and toxic epidermal necrolysis
by: Muddasir Sharief Banday, et al.
Published: (2023-01-01) -
Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022-01-01) -
Severe cutaneous adverse reactions in a tertiary care center in JamaicaCapsule Summary
by: Alicia J.S. McNish, BMedSc, MBBS, DM, et al.
Published: (2024-06-01) -
Long-term outcome of patients with severe cutaneous adverse reactions
by: Yoko Kano, et al.
Published: (2013-12-01)